Department of Cellular Pathology, Royal Free Hospital, London, UK.
Cytopathology. 2021 Mar;32(2):227-232. doi: 10.1111/cyt.12949. Epub 2021 Jan 7.
Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is an essential tool in the diagnosis of pancreatic lesions. The aim of this study was to evaluate the diagnostic accuracy of cytology from EUS-FNA, to correlate the results with the corresponding histopathological diagnoses and to analyse the impact of retrospective assignment of the Papanicolaou Society of Cytopathology (PSC) reporting system categories.
All pancreatic FNA specimens reported at the Royal Free Hospital during a 2-year period were retrospectively collected and assigned to the PSC system categories. Any available corresponding histological samples were assessed for concordance.
In total, 236 cytology specimens from 223 patients were identified, of which 108 (45.8%) had corresponding histology samples. The main reason for cyto-histological discrepancy was sampling error. Interpretive error was identified in one case. Overall, sensitivity was 92.5%, specificity was 100%, diagnostic accuracy of cytology was 95%, false-positive rate was 0% and false-negative rate was 7.5%. The implementation of the new reporting system reduced the number of cases in the atypical category. All cases previously categorised as suspicious or malignant remained in the same category.
EUS-FNA is an accurate method for evaluating pancreatobiliary lesions. The implementation of the Papanicolaou Society of Cytopathology diagnostic system enhances standardisation of the reporting terminology and reduces the number of samples in the non-standardised and equivocal atypical category.
内镜超声引导下细针抽吸术(EUS-FNA)是诊断胰腺病变的重要工具。本研究旨在评估 EUS-FNA 细胞学诊断的准确性,将结果与相应的组织病理学诊断进行比较,并分析回顾性分配巴氏细胞学会(PSC)报告系统分类的影响。
回顾性收集皇家自由医院在 2 年期间报告的所有胰腺 FNA 标本,并分配给 PSC 系统分类。评估任何可用的相应组织学样本以进行一致性评估。
共确定了 223 例患者的 236 个细胞学标本,其中 108 个(45.8%)有相应的组织学样本。细胞组织学差异的主要原因是取样误差。一个病例中发现了解释性误差。总体而言,敏感性为 92.5%,特异性为 100%,细胞学诊断的准确性为 95%,假阳性率为 0%,假阴性率为 7.5%。新报告系统的实施减少了非典型类别中的病例数量。所有以前归类为可疑或恶性的病例仍保留在同一类别。
EUS-FNA 是评估胰胆管病变的一种准确方法。巴氏细胞学会诊断系统的实施增强了报告术语的标准化,并减少了非标准化和模棱两可的非典型类别中的样本数量。